Unresectable Hepatocellular Carcinoma (HCC) research hub
3 indexed studies · 3 currently recruiting
- recruiting
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
This study looks at how a treatment called SIR-Spheres works for people with liver tumours that can't be removed by surgery. It collects information from real patients to see how well it works and if it's safe in everyday use.
France · Spain · United Kingdom - recruitingTherapeutic exploratory (Phase II)
Phase II Combination Study of NMS-01940153E and Atezolizumab with or without a prior priming with low dose decitabine for the Treatment of Adult Patients with Unresectable Hepatocellular Carcinoma (HCC) Previously Treated with Immune Checkpoint Inhibitors
This study is testing a new combination of medicines for adults with liver cancer that has spread too widely to be removed by surgery. It's for people whose cancer has already been treated with a type of immunotherapy. Researchers want to see how well these new combinations work.
Spain · Italy - recruitingTherapeutic confirmatory (Phase III)
A PHASE III, OPEN-LABEL, RANDOMIZED STUDY OF ATEZOLIZUMAB WITH LENVATINIB OR SORAFENIB VERSUS SORAFENIB OR LENVATINIB ALONE IN HEPATOCELLULAR CARCINOMA PREVIOUSLY TREATED WITH ATEZOLIZUMAB AND BEVACIZUMAB
This phase 3 clinical trial looks at adults with advanced liver cancer that cannot be removed by surgery. It tests whether combining an immunotherapy drip with targeted daily tablets helps people live longer and better compared to taking the standard targeted tablets on their own, after earlier treatment has stopped working.
Finland · Spain · Belgium